Eupraxia Pharmaceuticals Inc. EPRX.TO
Set alert
9.48 CAD -0.04 -0.42%
As of Nov 2, 3:07 PM ET
9.28 Day range 9.64
7.35 52-week range 13.08
- YTD
- -8.14%
- 1 year
- +18.50%
- Open
- 9.44
- Prev close
- 9.52
- Mkt cap
- 626.38M
- Vol
- 29.26K
- Avg vol
- 82.21K
- EPS
- -1.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.28
- High
- 9.64
- Forward P/E
- -6.77
- Beta
- 1.23
- Short ratio
- 0.72
- Inst. own
- 12.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.23
- 200-d avg
- 3.86
- 1y target
- 10.13
2Y chart
Events in this range
- Nov 14, 2024Rating: Rodman & Renshaw · — → Buy
Signals (99)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| RSI: Overbought | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 2 months ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 3, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Jan 20, 2026 | 9 months ago |
| RSI: Overbought | Jan 15, 2026 | 9 months ago |
| RSI: Overbought | Jan 8, 2026 | 9 months ago |
| RSI: Overbought | Jan 2, 2026 | 10 months ago |
| RSI: Overbought | Dec 23, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 18, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 5, 2025 | 11 months ago |
| SMA: Bearish | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 12 months ago |
| SMA: Bullish | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 24, 2025 | 1 year ago |
| SMA: Bullish | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 21, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 16, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
| RSI: Overbought | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 26, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| RSI: Overbought | Jul 10, 2025 | 1 year ago |
| RSI: Overbought | Jun 26, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 18, 2025 | 1 year ago |
| RSI: Overbought | Feb 20, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 17, 2025 | 1 year ago |
Key statistics
- Market cap
- 156.74M
- Enterprise value
- 136.94M
- Trailing P/E
- 0.00
- Forward P/E
- -6.77
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 54.32
- EPS (TTM)
- -1.33
- Beta
- 1.23
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -14.62M
- Total cash
- 23.32M
- Total debt
- 4.66M
- Return on equity
- -314.41%
- Shares outstanding
- 35.62M
- Short % of float
- 0.07%
- 50-day average
- 4.23
- 200-day average
- 3.86
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.13 +6.8% upside
Now 9.48
- Target (low)
- 8.25
- Target (mean)
- 10.13
- Target (high)
- 12.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy0
- Buy3
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.2025.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Rodman & Renshaw | init | — | Buy |
About Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidates are EP-104IAR, which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of eosinophilic esophagitis; and EP-104, under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. It also is involved in the development of product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Canada
- Website
- eupraxiapharma.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on EPRX.TO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Scotia Capital Inc. | 3.92% | 1,396,281 | 6.14M | Sep 29, 2024 |
| Royal Bank of Canada | 0.76% | 271,287 | 1.19M | Sep 29, 2024 |
| Bank of Montreal /CAN/ | 0.14% | 49,250 | 216.70K | Sep 29, 2024 |
| Goldman Sachs Group Inc | 0.10% | 34,500 | 151.80K | Sep 29, 2024 |
| UBS Group AG | 0.09% | 33,000 | 145.20K | Sep 29, 2024 |
| 180 Wealth Advisors, LLC | 0.04% | 13,000 | 57.20K | Sep 29, 2024 |